Citadel Advisors’s AMERISAFE AMSF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,100
Closed -$273K 12908
2025
Q4
$273K Buy
+7,100
New +$286K ﹤0.01% 10355
2025
Q2
Sell
-1,600
Closed -$84.1K 12397
2025
Q1
$84.1K Sell
1,600
-1,100
-41% -$55.8K ﹤0.01% 11700
2024
Q4
$139K Buy
2,700
+1,500
+125% +$81.2K ﹤0.01% 10999
2024
Q3
$58K Sell
1,200
-2,100
-64% -$99.9K ﹤0.01% 11744
2024
Q2
$145K Sell
3,300
-200
-6% -$9.17K ﹤0.01% 10395
2024
Q1
$176K Buy
+3,500
New +$174K ﹤0.01% 10534

Other funds holding AMSF

Citadel Advisors's AMSF Position: Q2 2026 in Review

Citadel Advisors increased its AMERISAFE (AMSF) stake by 30% in Q2 2026, buying an estimated $2.76M and bringing the position to 376,251 shares worth $12.7M. The position accounts for ﹤0.01% of the portfolio, ranked #3209.

Citadel Advisors first reported a position in AMSF in Q2 2013 and has held it in 49 quarters since. 215 funds tracked by Wall St. Rank hold AMSF as of Q2 2026.

  • Citadel Advisors held 376,251 shares of AMERISAFE worth $12.7M as of Q2 2026.
  • Citadel Advisors bought 87,169 AMERISAFE shares in Q2 2026, an estimated $2.76M.
  • AMERISAFE made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #3209 holding.
  • Citadel Advisors first reported a position in AMERISAFE in Q2 2013 and has held it in 49 quarters since.
  • 215 funds tracked by Wall St. Rank held AMERISAFE as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.